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INTRODUCTION
The essential fatty acid (EFA) requirement for common carp (Cyprinus carpio) can be met by 1.0% of the C 18 polyunsaturated fatty acids (PUFA), α-linolenate (18:3n-3) and/or linoleate (18:2n-6) . 1 A cell line from carp, EPC (epithelial papilloma) 2 was shown to be able to convert the C 18 PUFA to long-chain highly unsaturated fatty acids (HUFA) such as arachidonic (20:4n-6) , eicosapentaenoic (EPA; 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) acids. 3 We developed a cell line, EPC-EFAD, derived from EPC cells, that can survive and proliferate in an essential fatty acid-deficient (EFAD) medium based on delipidated serum despite containing virtually no n-3 and n-6HUFA. 4, 5 We have used these cell lines to investigate HUFA production and the pathways of fatty acid desaturation and elongation. Both cell lines desaturated the n-3 fatty acids, [1- 14 C] 18:3n-3 and [1- 14 C] 20:5n-3, to a greater extent than the n-6 fatty acids, [1- 14 C] 18:2n-6 and [1- 14 C] 20:4n-6. 3 However, the desaturation of all the radiolabelled PUFA was significantly greater in EPC-EFAD cells compared to EPC cells. 3 The metabolism of [1- 14 C] 18:3n-3 was primarily increased in EPC-EFAD cells at the level of Δ5 desaturase and page 5 subsequent steps in the pathway with DHA production being 4.4-fold greater in the EFAD cells. 3 In a recent study, the effects of competing, unlabeled C 18 PUFA, 18:2n-6, 18:3n-3, 18:3n-6 and 18:4n-3, on the metabolism of [1- 14 C] 18:3n-3 were investigated. 6 The incorporation of [1- 14 C] 18:3n-3 in both EPC and EPC-EFAD cell lines was significantly reduced, and the proportions of radioactivity recovered in DHA, pentaene and tetraene products significantly decreased, by competing C 18 PUFA. 6 However, the inhibitory effect of competing C 18 PUFA on the desaturation of [1- 14 C] 18:3n-3 was significantly greater in EPC-EFAD cells although the mechanism for this was unclear. The magnitude of the inhibitory effects of C 18 PUFA on [1- 14 C] 18:3n-3 desaturation was dependent upon the specific fatty acid and its position in the fatty acid desaturation pathway with, for instance, 18:4n-3 producing a greater inhibition than 18:3n-3. Thus the effects of 18:4n-3 were probably a combination of product inhibition of Δ6 desaturation of [1- 14 C] 18:3n-3 and also by direct substrate competition for C [18] [19] [20] elongase and subsequent steps in the pathway.
In summary, the previous studies had shown that the main effect of essential fatty acid deficiency on fatty acid desaturation in carp cells was increased production of DHA, that competing fatty acids showed far greater inhibition of fatty acid desaturation in EPC-EFAD cells, and that competing acids had differential effects based on their position in the desaturation/ elongation pathway. Therefore, in the present study, rather than looking at the effects of competing substrate fatty acids, we have investigated the effects of DHA, as both final end product of the pathway and as the HUFA whose production is most influenced by EFA deficiency, on the metabolism of [1- 14 C] 18:3n-3 in EPC and EPC-EFAD cells. Specifically, both cell lines were grown in the presence or absence of DHA after which the cultures were washed and the activities of the fatty acid desaturation/ elongation pathway were determined by incubation with [1- 14 C] 18:3n-3. The effects on fatty acid incorporation and desaturation were page 6 determined and related to the effects of DHA supplementation on cellular lipid and fatty acid compositions.
MATERIALS AND METHODS

Cells and media
The carp (Cyprinus carpio) epithelioma papillosum (EPC) cell line, which retains epithelial morphology, was routinely maintained in Leibovitz L-15 medium and supplemented with 2 mM glutamine, antibiotics (50 I.U. ml -1 penicillin and 50 mg.ml -1 streptomycin) and 10% fetal bovine serum (FBS). 2 EPC-EFAD cells were derived from EPC cells by subculture in Leibovitz L-15 medium with exactly the same supplements except that the FBS was delipidated prior to use, essentially as described by Capriotti and Laposata. 7 Delipidated serum had been used previously to develop cultured mammalian cell lines that can grow in the absence of EFA. [8] [9] [10] The delipidated FBS contained approximately 10 µg of fatty acids per g of serum (0.001% by weight) with less than 2 µg/g of C 18 PUFA, predominantly 18:2(n-6). 4, 5 The EPC-EFAD cells used in the experiments had been maintained continuously in delipidated medium for over 5 years and were at passage number 100.
Incubation conditions
The EPC and EPC-EFAD cells were cultured at 22 o C in sealed plastic tissue culture flasks.
EPC cells were cultured in standard tissue culture flasks (Iwaki Flasks, Asahi Techno Glass, Chiba, Japan), whereas the EPC-EFAD line was cultured in surface-modified "Primaria" flasks (Falcon, Becton Dickinson UK Ltd., Oxford 
Lipid extraction and incorporation of radioactivity into total lipid
The medium was aspirated and cultures washed twice with 20 ml of ice-cold HBSS. Cells were 
Separation of total polar lipids and fatty acid analysis
Samples of total lipid (300 µg) were applied as 3 cm streaks to thin-layer chromatography (TLC)
plates, and polar lipids separated from neutral lipids using hexane/diethyl ether/acetic acid (90:10:1, by vol.) as developing solvent. The origin area corresponding to total polar lipids was scraped into stoppered conical glass test tubes for transmethylation directly on the silica. 16 Fatty acid methyl esters (FAME) of total cell lipid or total polar lipids, purified as above, were prepared by acid-catalyzed transmethylation, and extracted and purified by high-performance TLC (HPTLC) as described previously. 17 Analysis of FAME was performed by capillary gas chromatography in a Fisons GC8000 gas chromatograph (Crawley, UK) equipped with a fusedsilica capillary column (30m x 0.32 mm i.d., CP Wax 52 CB, Chrompack, UK) using hydrogen as carrier gas. Temperature programming was from 50 to 150°C at 35°C/min and to 225°C at page 9
2.5°C/min. Individual FAME were identified by comparison with known standards and published data.
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Incorporation of radioactivity into polyunsaturated fatty acids TLC plates were impregnated by spraying with 2 g silver nitrate in 20 ml acetonitrile and activated at 110 o C for 30 min. Total lipid FAME were applied as 2.5 cm streaks and plates developed with toluene/acetonitrile (95:5, v/v) to separate PUFA. 20 Autoradiography was performed using Kodak MR2 film for 6 days at room temperature. Silica corresponding to different FAME was scraped into scintillation vials containing 2.5 ml scintillation fluid and radioactivity determined as described above. 
Materials
Statistical analysis
All results are means + SD of three experiments. Where indicated, data were subjected to twoway and/or one-way analysis of variance (ANOVA) to determine the significance of effects due to cell line and fatty acid supplement, and where appropriate the significance of differences were page 10 determined by Tukey's post-test. Percentage data were subjected to arc-sin transformation prior to further statistical analysis. Differences are reported as significant when p < 0.05.
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RESULTS
The lipid contents and class compositions of the EPC and EPC-EFAD cell lines are shown in Table 1 . The data were subjected to two-way analysis of variance (ANOVA) to determine the significance of effects due to EFA deficiency and DHA supplementation ( Table 2 ). The lipid content of the cells relative to protein content was not significantly affected by EFA deficiency and DHA supplementation also had no significant effect in either cell line. EPC-EFAD cells were characterised by significantly decreased proportions of cholesterol and phosphatidylcholine (PC), and significantly increased proportions of phosphatidylethanolamine (PE), phosphatidylinositol (PI) and total polar lipids (Tables 1 and 2 ). Supplementation with DHA significantly increased the proportions of total polar lipids in both cell lines. However, whereas DHA supplementation decreased the proportions of cholesterol and PE and increased the proportion of PC in EPC cells, it had little effect on the relative proportions of these three major lipid classes in EPC-EFAD cells (Table 1) .
There was no significant difference in total fatty acid content of the two cell lines when the results were expressed relative to protein content and although DHA supplementation tended to increase the total fatty acid content in both cell lines, these effects were non significant (Table 3) .
Expressing the total lipid fatty acid composition of the cell lines relative to cell protein content showed that EPC-EFAD cells contained very reduced amounts of n-6 and n-3 PUFA which was compensated entirely by increased amounts of n-9 PUFA so that total PUFA content was identical in the two cell lines. The levels of saturated fatty acids in total lipid were slightly lower in EPC-EFAD cells mainly due to reduced 16:0 and 18:0 whereas the levels of total page 11 monounsaturated fatty acids were identical in the two cell lines despite EPC-EFAD cells showing a lower level of 18:1n-9. DHA supplementation increased the levels of DHA, 22:5n-3, EPA, total n-3PUFA, total PUFA and total saturated fatty acids in total lipid in both cell lines and decreased the amounts of n-9 PUFA and monoenes, particularly 18:1n-9 (Table 3 ). These effects of DHA supplementation tended to be quantitatively greater in EPC cells but, in particular, the level of EPA was increased in EPC cells to a level over 3-fold greater than in EPC-EFAD cells.
Similar patterns were observed in the fatty acid compositions of polar lipids (Table 4) . EPC-EFAD cells showed reduced proportions of n-6 and n-3 PUFA, compensated by increased n-9
PUFA, along with a lower proportion of saturated fatty acids and similar a level of total monounsaturated fatty acids despite EPC-EFAD cells showing a lower proportion of 18:1n-9 compared to EPC cells. As with total lipid, DHA supplementation decreased the proportions of n-9 PUFA and monoenes, particularly 18:1n-9, in polar lipid in both cell lines and increased the proportions of saturated fatty acids, DHA, 22:5n-3, EPA, total n-3PUFA and total PUFA with the percentage of EPA increased in EPC cells to a level over 3-fold greater than in EPC-EFAD cells ( Table 4 ).
The incorporation of [1- 14 C] 18:3n-3 was significantly greater in EPC-EFAD cells compared to EPC cells and DHA supplemenation had no significant effect on this (Fig.1) . In contrast, the conversion of [1- 14 C] 18:3n-3 to all desaturation products (sum total of radioactivity recovered as desaturated products including 18:4n-3, 20:4n-3, 22:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3) was not significantly different between EPC and EPC-EFAD cells but DHA supplementation significantly reduced the destauration of [1- 14 C] 18:3n-3 in both cell lines (Fig.2, top panel) . This was mainly a reflection of the effects on the production of tetraene products, which accounted for approximately 45% (EPC + DHA) to 64% (EPC-EFAD + DHA) of the total desaturated products page 12 (Fig.2, middle panel) . Pentaenes products accounted for between 33% (EPC-EFAD + DHA) and 50% (EPC + DHA) of the total desturated products and also showed no significant difference between cell line but were significantly reduced in DHA supplemented cells (Fig. 2, bottom panel). However, the reduction in radioactivity recovered in pentaene products was significantly greater in EPC-EFAD cells. Two-way ANOVA confirmed that incorporation of [1- 14 C] 18:3n-3
was only affected by cell line and not DHA supplementation, whereas desaturation of [1- 14 C]18:3n-3 to all desaturated products and tetraenes was only significantly affected by DHA supplementation and not by cell line whereas production of pentaene products was also significantly affected by cell line (Table 5 ). However, the production of DHA from [1- 14 (Fig. 3) . Two-way ANOVA showed the very significant interaction between effects due to cell line and DHA supplementation on DHA production from [1- 14 C] 18:3n-3, i.e. the effects of DHA supplementation were highly dependent upon cell line and as the difference between EPC and EPC-EFAD cell lines was completely reversed by supplementation with DHA (Table 5 ). In contrast, the effects due to cell line and DHA supplementation were entirely independent for incorporation and conversion of [1- 14 C] 18:3n-3 to other desaturation products (Table 5) .
DISCUSSION
The primary aim of the present study was to determine the effects of DHA, as the end product of the PUFA biosynthetic pathway, on PUFA desaturation/elongation in a cell culture model of EFA deficiency, the EPC-EFAD cell line, in comparison with the non-deficient line, EPC. In page 13
addition, the study aimed to relate the effects on the PUFA biosynthetic pathway in the cell lines with changes in the fatty acid composition of the cellular lipids. PUFA desaturation were observed mainly on DHA production, with this being increased by EFA deficiency. However, DHA supplementation only significantly inhibited DHA production in EPC-EFAD cells and similarly, the suppression of pentaene production by DHA supplementation was greater in EPC-EFAD cells compared to EPC cells.
Net "incorporation" is based on the recovery of radioactivity in the cells and will be dependent on the initial uptake of fatty acid less the amount of fatty acid oxidized or lost through other metabolic pathways. We had shown previously that incorporation of PUFA is increased in the cell culture model of EFA deficiency, EPC-EFAD cells, compared to their non-deficient parent cells, EPC. 3, 6 In a recent dietary trial, the incorporation of 18:2n-6 and 18:3n-3 was increased in hepatocytes from Atlantic salmon (Salmo salar) fed an EFA deficient diet compared to one fed an n-3-supplemented diet. 22 The present study has confirmed this result but also showed that prior supplementation of the cells with DHA did not affect the PUFA uptake and incorporation processes in either cell line. The present study was performed under conditions where neither cell line was metabolically predisposed to storing lipid. 23 This is perhaps obvious with EPC-EFAD cells, being cultured in delipidated FBS, but even culture in 10% FBS does not lead to the deposition of lipid in the form of lipid droplets in the EPC cell line and so levels of page 14
neutral lipid in both cell lines are low. 3 Similarly, we have shown previously that supplementation with PUFA at 20 µM is able to significantly alter fatty acid compositions of phospholipids without significantly increasing neutral lipid in these cells. 5 Therefore, the DHA supplementation used in the present study was sufficient to dramatically increase DHA levels in polar lipids in both cell lines without inducing any increase in neutral lipid stores. In consequence, the results show that an increase in membrane DHA alone did not affect apparent processes of uptake and incorporation of [1- 14 The EPC-EFAD cells have now been cultured continuously in delipidated FBS for over 5 years and 100 passages. Lipid content per cell is lower in the EPC-EFAD cells compared to EPC cells 3 but the present study showed that the lipid content relative to cell protein is similar in the two cell lines and EFA deficiency had only relatively minor effects on phospholipid class composition. Therefore, the main effects of EFA deficiency were on fatty acid compositions which were characterised in EPC-EFAD cells by increased n-9PUFA, particularly 20:2n-9 and 20:3n-9, balancing the very reduced levels of n-3 and n-6PUFA. The reduced amount of 18:1n-9, possibly related to increased metabolism to n-9PUFA, was compensated by increased levels of the other monoenoic fatty acids. These differences between EPC and EPC-EFAD cells are presumably adaptations to maintain the fluidity of the cellular membranes and, consistent with this, reduced cholesterol in the EPC-EFAD cells, as observed in the present study, has also been a consistent feature of EFA deficiency in this cell culture model. 3, 4 Other studies on mammalian cell culture models of EFA deficiency have reported broadly similar changes in fatty acid composition but have not reported lipid class compositions and so the effects of EFA deficiency page 15 on cholesterol levels in these cells is not known. [8] [9] [10] 24, 25 The present study clearly demonstrated that there was no difference between EPC and EPC-EFAD cells in the amount of [1- 14 C] 18:3n-3 desaturated to tetraene and pentaene products, i.e.
no overall difference in the apparent activities of Δ6 and Δ5 desaturases and C [18] [19] [20] elongase. This is slightly surprising as mammalian dietary studies have generally suggested that Δ6 (and perhaps Δ5) desaturase activities are upregulated by "EFA deficiency" although the dietary modulation has actually been a fat-free diet rather than a diet specifically and solely devoid of PUFA. 26 However, endocrine/hormonal factors almost certainly have critical roles in regulating fatty acyl desaturase activities in response to nutritional status and so it is probably not appropriate to directly compare cell culture studies with whole animal nutritional trials. 27, 28 Few data are available on fatty acyl desaturase activities in cell culture models of EFA deficiency but it has been reported that both Δ6 and Δ5 desaturase activities were upregulated in human HepG2 cells in EFA deficient conditions although this was a short term, acute deficiency (2 weeks) compared to the long-term adapted EPC-EFAD line.
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In an earlier study with EPC-EFAD cells, expressing the results as percentage of substrate desaturated rather than the absolute terms used in the present study, we noted that there was increased desaturation of both [1- 14 C] 18:3n-3 and [1- 14 C] 18:2n-6 in EPC-EFAD cells compared to EPC cells. 3 In that study however, the greatest increase in [1- 14 C] 18:3n-3 desaturation in EPC-EFAD cells was in DHA production, which was relative proportion in total fatty acids was also increased in both cells lines in respose to DHA supplementation, with general membrane fluidity requirements being compensating by increased saturated fatty acids and decreased monoenes, particularly 18:1n-9 which was reduced to similar levels in EPC and EPC-EFAD cells. The effects of DHA supplementation on fatty acid compositions in EPC-EFAD cells were similar to those observed in a previous study which had shown that, like the present study, supplemental DHA was, in part, retroconverted to EPA in EPC-EFAD cells. 5 However, EPC cells were not investigated in the previous study. The present study has shown that the process of retroconversion was considerably greater in EPC cells such that EPA levels were some 3-fold higher in DHA-supplemented EPC cells than in DHAsupplemented EPC-EFAD cells. DHA levels before DHA supplementation are almost 10-fold higher in EPC cells compared to EPC-EFAD cells and so it appears that this level of DHA, although not high in absolute terms, may result in more of the supplemental DHA being retroconverted. In effect, retroconversion of DHA, which requires saturation of the Δ 4 double bond by 2,4-enoyl-CoA reductase and peroxisomal chain shortening via limited β-oxidation, appears to be inhibited by EFA deficiency. Retroconversion of DHA to 22:5n-3 and EPA has been observed previously in various animal tissues [30] [31] [32] and retroconversion of DHA to 22:5n-3 and EPA, and 22:5n-3 to EPA has been reported in various cells in culture. 22, [33] [34] [35] In contrast, in rat U III (uterine stromal) cells, which show higher levels of DHA production from 18:3n-3 than most other cell lines, there was no significant retroconversion of DHA, added at 5 µM. 36 To our knowledge the effects of EFA deficiency on retroconversion processes in cell cultures has not been reported previously, but retroconversion of DHA to EPA and 22:5n-3 was reported to be increased in hepatocytes prepared from salmon fed an EFA deficient diet in comparison with hepatocytes from salmon fed an n-3PUFA supplemented diet. 22 Prior supplementation with DHA also very significantly reduced the page 17 desaturation/elongation of [1- 14 C] 18:3n-3 to tetraene and pentaene products in both cell lines.
This could be interpreted as being consistent with end-product inhibition as a result of greatly increased membrane DHA levels. Certainly, inhibition or repression of Δ6 and Δ5 desaturase activities in response to feeding fish oils, rich in DHA (and EPA) is a consistent observation of dietary trials in mammals. 26, 37 An unexpected result in the present study was the greater effect of DHA in inhibiting DHA and, to a lesser extent, pentaene production in EPC-EFAD cells compared to EPC cells. A possible explanation could be that the level of DHA in EPC cell polar lipids is sufficient to exert a suppressive effect on DHA synthesis that is not increased by a further increase in DHA level but which is reduced by EFA deficiency. This would imply that the presence or absence of end product DHA can only affect DHA production in these cells by an order of 2-fold. An alternative explanation could be that the apparent inability of DHA to inhibit DHA production in EPC cells was related to the level of EPA, produced through retroconversion of the added DHA. Increased EPA may stimulate the conversion of EPA to DHA and thus counteract the suppressive effect of DHA.
In conclusion, the present study determined the effects of DHA, as the end product of the PUFA biosynthetic pathway, on PUFA desaturation/elongation in a cell culture model of EFA deficiency, and attempted to relate the effects on the PUFA biosynthetic pathway with changes in the fatty acid composition of the cellular lipids. The results showed that the effects of DHA supplementation were generally similar in both EPC and EPC-EFAD cells. However, whereas DHA supplementation inhibited biosynthesis of DHA from [1- 14 C] 18:3n-3 in EPC-EFAD cells, it had no effect on DHA synthesis in EPC cells. This may be related to the differing levels of DHA and/or EPA between EPC and EPC-EFAD cells both prior and subsequent to DHA supplementation.
